In Vitro Glucose Utilization in ob/ob Mouse Erythocytes & Adipose Tissue by Fudge, Peggy
Western Kentucky University
TopSCHOLAR®
Masters Theses & Specialist Projects Graduate School
8-1984
In Vitro Glucose Utilization in ob/ob Mouse
Erythocytes & Adipose Tissue
Peggy Fudge
Western Kentucky University
Follow this and additional works at: https://digitalcommons.wku.edu/theses
Part of the Biology Commons
This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by
an authorized administrator of TopSCHOLAR®. For more information, please contact topscholar@wku.edu.
Recommended Citation






IN VITRO GLUCOSE UTILIZATION IN ob/ob MOUSE
ERYTHROCYTES AND ADIPOSE TISSUE
A Thesis
Presented to









AUTHORIZATION FOR USE OF THESIS
Permission is hereby
ui 
granted to the Western Kentucky University Librar
y to
make, or allow to be made photocopies, microfilm 
or other
copies of this thesis for appropriate research or 
scholarly
purposes.
reservc..‘cl to the author fe'r the rnricir-::: of any copies of
 tl.is





Please place ":." nLhc approprir-te box.
This form r7.1 the original of the th
esis and will control
future use of th.1. c
IN VITRO GLUCOSE UTILIZATION IN ob/Ob MOUSE











I wish to express my gratitude and appreciation to
Dr. D. Hugh Puckett, chairman of my committee, for his
assistance and guidance throughout this study. I thank the
other members of my committee, Dr. Frank R. Toman for his
technical assistance and Dr. Robert D. Hoyt for his
editorial guidance in the preparation of this paper. I
thank Joe ialker, Temple University, who provided the
experimental animals. Also I wish to thank the faculty
and staff of the Department of Biology for their encourage-
ment. 3pecial thanks goes to my fellow graduate students
for their support and tolerance. I thank my patient and
helpful typist, my brother, Jim Fudge. Most of all,
thank my parents, John and Betty Fudge, for their endless





ACKNOWLEDGEMENTS  i i i
LIST OF FIGURES 
LIST OF TABLES  vi
ABSTRACT  vi
INTRODUCTION  1








4.1  Glucose Utilization by Erythrocytes  12
2. Glucose Utilization by Epididymal Fat  14
LIST OF TABLES
Table Page
1. Glucose Utilization by Erythrocytes  11
2. Glucose Utilization by Epididymal Fat  13
IN VITRO GLUCOSE UTILIZATICN IN ob/ob MUSE
ERYTHROCYTES AND ADIPOSE TISSUE
Peggy J. Fudge May 1984 22 pages
Directed by: Hugh Fuckett, frank foman, and Robert Hoyt
Department of Biology Western Kentucky University
An ia vitrsz study of ob/ob mouse and control mouse
erythrocytes and adipose tissue showed a difference in the
rate of glucose utilization as determined by the production
of 'H20. In both ob/ob and control erythrocytes, glucose
utilization increased as glucose concentration of the medium
was increased, although the ob/ob rate was consistently
lower than the control. The
similar trend except for the
adipose tissues showed a
ob/ob adipose tissue at 200
mg/d1 glucose concentration which exhibited a rate less than
the rate at 100 mg/d1.
The decreased glucose utilization by adipose tissue in
the absence of insulin or other hormonal stimuli suggested
that the difference may be due to a defect at the cellular
level rather than a hormonal effect. Because erythrocyte
glucose utilization is not regulated by insulin, the results
of those incubations supported this idea. The decreased
glucose utilization by the ob/ob erythrocytes gave further
evidence to the location of the defect. 3ince glucose
utilization in these cells is restricted to glycolysis and
to a lesser extent the pentose phosphate pathways the defect
would necessarily be limited to these pathways as well.
INTRODUCTION
The genetically obese mouse (ob obi was first described
in 1950 by Ingalls et al. In America and :;candanavia the
mutation has been maintained on a background stock of
C57b1/6J mice (Bray and York 1979). It has been demonstrated
that the defect is an autosomal recessive mutation on
chromosome six, 14 centimorgans from the ig gene (Margules
1978). fhe features exhibited by this mouse include obesity,
hyperglycemia, hyperinsulinemia, and insulin resistance
(hlouverakis and Ahite 1969; Genuth 1969; ;enuth et al.
1971; Findlay et al. 1973). The syndrome in first expressed
by an observable weight gain by day 17-21. according to Bray
and York (1979). The serum insulin level rises slightly at
this time and an accompanying hypoglycemia ensues, which is
eventually replaced by hyperglycemia. Hyperplasia and
nypertrophy of adipose tissue continue until about six
months, when the condition stabilizes and the mouse has
reached an average weight of seventy-five grams. Deficient
non-shivering thermogenesis (e.g., fatty acid oxidation by
brown adipose tissue or skelatal muscle) has been reported
by some authors as the first detectable abnormality
(Trayhurn et al. 1977; Carnie and Smith 1980). There is
much disagreement about the nature of the primary defect.
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although there is agreement concerning ths major character-
istics of the syndrome.
Altered function of pancreatic beta-cells has been
suggested as the cause of the hyperinsulinism and hence the
other characteristics (Genuth 1969; Ashcroft et al. 1970).
This idea was supported by Strautz (1968) who demonstrated
an ame1iorati3n of obesity and related symptoms by implanta-
tion of normal islets into the ob/ob mouse pancreas. This
procedure resulted in reduction of serum insulin levels to
near normal. Abraham et al. (1971) suggested that hyper-
secretion of insulin is secondary to an increased food
intake. Genuth (1969) also presented evidence supporting
hyperphagis as the cause of hyperinsulinism. Chlouverakis
and v,hite (1969) also reported improvement of the symptoms
of the syndrome when the ob/ob mice were maintainej on a
restricted diet. Insulin resistances according to several
authors, is a result and not the cause of obesity and
hyperphagia (Chlouverakis and White 1969; Genuth et al.
1971; Beloit-Chain et al. 1973). Raitada et al. (1980),
however, reported results showing decreased numbers of
insulin receptors in cultured ob/ob fibroblasts even after
several generations.
More recently, investigations to determine whether
altered glucose uptake and metabolism sre possible causes
or effects of the syndrome have been reported. Cuendet
et al. (1976) has shown decreased glycolysis and 2-deoxy-
glucose uptake in the soleus muscle of the ob/ob mouse nnd
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has suggested that a defect may be present in the transport
of glucose across the cell membrane or in phosphorylation.
A defect in glucose transport across cell membranes may
also be found in other tissues of thc ob/ob mouse. Because
of the obvious importance of pancreatic islet cells in tne
development of the syndrome, investi:.ation of the islets could
be expected to yield results that would help determine the
role of islet cell defects in causing the syndrome. If, as
has been suggested, insulin release is controlled by glucose
processing up to the triose phosphate step (Coll-Garcia and
Gill 1969), then defective glucose transport or phosphoryla-
tion in pancreatic islets may play a role in aberrant insulin
production or secretion. The idea of defective islet glucose
utilization and excess insulin secretion are not necessarily
contradictory. According to Lavine et al. (1977). the blood
glucose level in the ob/ob mouse is above the insulin
stimulus threshold. This could account for the high insulin
levels despite an islet cell abnormality. That is, even if
the ob/ob islets show defective insulin secretion, the blood
glucose level is high enough to provide a continuous
stimulus for insulin secretion resulting in hyperinsulinism.
Strautz (1970) and Batchelor et al. (1975) supported the
possibility of the importance of an intrinsic islet cell
defect by suggesting that abnormalities in other tissues,
perhaps adipose tissue, may also play an important role in
the development of the syndrome. It would then be reasonable
to look for a defect in glucose utilization by adipose
tissue. Jefective glucose uptake and utilization, however,
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have been observed in vitro in ob/ob mouse muscle in the
absence of insulin ;Cuendet et al. 1976). ihese results
suggested that the effects of insulin on the target tissue
may not be the primary cause of the disease. If the insulin
effects are a conseluence and not a cause of the syndrome,
the tissues which exhibit glucose utilization and uptake
independent of insulin (e.g., erythrocytes and lens of the
eye) may also show abnormalities in those processes.
rhe purpose of this study was to determine the rate of
non-insulin stimulated glucose ut!,lization by islets of
Langerhans, epididymal fat segments, and erythrocytes.
Pancreatic islets were chosen because of their importance
in the development of the obese syndrome. Adipose tissue was
selected because it is a major insulin target tissue and fat
deposition is the most visible characteristic of the syndrome.
Erythrocytes were chosen because their rate of glucose
transport and metabolism is not regulated by insulin. Also,
fed corpuscles do not carry out respiration, glucose being
metabolized via glycolysis and the pentose phosphate pathway.
Deficient glucose utilization in erythrocytes would more
specifically indicate the location of that defect than would
deficient utilization of glucose in tissues with more
complex metabolism. A defect in glucose utilization should,
since glucose metabolism in erythrocytes is limited to
glycolysis and the pentose phosphate shunt, indicate a
problem in some step in those pathways. Deficient glucose
5
uptake could also be eliminated as a cause of ,1 decreased
rate of metabolism since free glucose is found in red blood
cells.
7
the evolved tritiated water to the outer vial. The vial
was removed from the water bath and allowed to cool to room
temperature. rhe rubber stopper and inner vial were removed.
10 ml toluene-trition scintillation fluid was added to the
glass vial, and the radioactivity of the evolved water was
determined. The counts per minute (CPM) obtained were
corrected by subtracting from the vial CPM the CPM from a
vial with no tissue. The corrected CPM of each vial were
divided by the total CPM in the original medium. This
proportional fraction was then multiplied by the micrograms
of glucose in the original sample to obtain the amount of
glucose used by that tissue. This procedure measured glucose
utilization by assessing the total flux down the glycolytic
and pentose phosphate pathways (Larkins et al. 1980). It is
based on the fact that in the triose phosphate isomerase
reaction, or the enolase reaction, the 3H of the (5-3H)
glucose is lost to water (Ashcroft et al. 1970). The
amount of water evolved was determined by liquid scintilla-
tion counting and the glucose used is calculated by relating
that fraction to the amount of glucose in the original
medium (Larkins et al. 1980.
Blood was obtained from the abdominal aorta and
collected in lightly heparinized tubes. The tubes were
flame-sealed and spun five minutes in a hematocrit
centrifuge. me packed erythrocytes were removed from the
capillary tubes with a ?2 gauge needle and glass syringe
rinsed with normal saline. 2he erythrocytes were washed
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three times in 0.85% saline (pH 7.4). rhe supernatant was
drawn off after the last washing,and lOul of packed
erythrocytes were placed in lOul of KRB solution in the inner
vial of the apparatus previously described for incubation.
Glucose utilized WRS recorded as micromoles of glucose
utilized per gram of hemoglobin per hour.
Pancreatic islets of Langerhans were isolated for
incubation bv using a variation of the technique described
by Lacy and Kostianovsky (1967). The pancreas was removed
and trimmed of all fat, washed in Hank's solution, and cut
into pieces 2-4 mm in diameter. These pieces were then
placed in a lass conical centrifuge tube and washed in
several changes of Hank's solution until no fat was observed
in the solution. The supernatant was drawn off with a
Pasteur pipette. Two milligrams of type V collag,enase
(Sigma) were added to the tube to digest the exocrine matrix
and free the islets. The tube was then capped and shaken
rapidly by hand in a water bath at 37 C until the endpoint was
reached. The endpoint could be identified by close observa-
tion of the liquified mixture: within two minutes after
addition of the enzyme, the pancreatic tissue began to form
a sheet along the side of the tube. Small breaks began to
appear in the sheet after 5-8 minutes of incubation. Enzy-
matic digestion was stopped t this point by the addition of
5 ml of ice-cold Hank's solution. This mixture was spun at
low speed on a bench centrifuge for two minutes and the
supernatant decanted. This procedure was repeated a total of
MATERIAL-3 AND METHODS
Animals used in this experiment were male C57b1/6J ob/ob
mice and their lean siblings, aged 52 weeks, which were
obtained from Temple University, Moe were fed laboratory
rat chow a.1 libitum until they were sacrificed. Mice were
first paralysed by severing the spinal cord so fresh blood
specimens could be obtained. The animals were then killed
and tissues incubated as described below.
The procedure employed for incubation of tissues was
tnat described by Ashcroft et al. (1972), Larkins et al.
(1980), and Goodman and Coiro (1981). A 2 ml plastic vial
(Technicon) was placed in a 20 ml glass scintillation vial.
The inner vial contained approximately 1 microcurie of
D-(5-3H) glucose (New England Nuclear) and Krebs-Ringer
bicarbonate medium (pH 7.4) at a volume of lOul with the
erythrocytes or 50u1 with adipose tissue or pancreatic
islets. The KRB medium contained 3.5 mg/ii bovine albumin
and either 50, 100 or 200 mg/d1 glucose. After addition of
the erythrocytes, islets, or fat segments to the inner vial,
the outer vial was sealed with a rubber stopper. The
apparatus was incubated for one hour in a shaking water bath
at 100 strokes per minute at a temperature of 37 C.
Metabolism was stopped after one hour by the injection of
5u1 of 0.4 N HCI t the inner vial via a needle inserted
through the rubber stopper. The apparatus was incubated an
additional 20 hours to allow evaporation and condensation of
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five times. The last wash was carried out in Krebs-Ringer
bicarbonate medium with a glucose concentration of either
50, 100, or 200 mg/di. The islets and medium were poured
into a flat gla,3s dish, placed on a dark background, and
were examined under a dissecting microscope. Free islets
were removed with a capillary tube and transferred to the
inner vial of the incubation apparatus. Seven islets in
50u1 of KRB medium were incubated in each vial according
to the procedure described above. Glucose utilization was
reported as picomoles of glucose per islet per hour.
Adipose tissue was taken from the epididymal fat pad.
Samples weighing- 0.012-0.018 g were taken from the distal
portion of the fat pad and washed in normal saline. Each
segment was incubated in 50u1 KRB medium ,hith a glucose
concentration of either 50, 100. or 200 mg/di. Results
were reported as micromoles of glucose utilized per gram
of tissue per hour.
Statistical analyses of the results obtained from each
of the tissues were made using the Student t-test.
RESULTS
Erythrocyte studies were carried out at 100 and 200
mg/al glucose, and significantly different results were
obtained at both concentrations (Figure 1). The glucose
utiliztion by the ob/ob cells WRS significantly lower at
both levels than the rate of the control cells (Table 1).
At 100 mg/di glucose concentration, the mean rate of
utilization by the control erythrocytes was _.35uM glucose/
gram hemoglobin/hour, while that of the obere mice was
3.59uM glucose/gram hemoglobin/hour (Table 1; Figure 1).
At 200 mg/dl glucose, the control rate was 11.02uM
glucose/gram hemoglobin/hour. The ob/ob erythrocyte rate
was 8.21uM/gram hemoglobin/hour (Table Figure 1).
Comparisons made between the control and ob/ob cells with
the Student t-test showed significance at the 0.01 level.
Determinations carried out with adipose tissue also showed
a significant difference between control and ob/ob tissues
(Table 2). Glucose utilization in adipose tissue taken from
obese and from control animals was determined at all three
concentrations' 50, 100, and 200 mg/al. At 50 mg/al, the
mean rate of glucose utilization for control tissues WRS
2.60uM glucose/gram tissue/hour and 0.99uM for ob/ob
tissue (Table 2; Figure 2). The control rate was 3.74uM
10
TABLE 1
GLUCOSE UTILIZATION BY ERYTHROCYTES
Glucose No. of Glucose level
conc. Repli- Utilized of








control 5 11.02 0.46
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ob/ob 7 0.99 0.14
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control 5 3.64 0.83
t • •
Fig. 2 Glucose Utilization by Epididymal Fat. 0 control
E1.3 ob/Ob.
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glucose/gram tissue/hour nt 100 mg/d1 concentration, while
the ob/ob rate was 1.69uM (Table 2; ?igure 2). At 200 mg/al,
the rate increased in the control tissue, but not in the
ob/ob tissue. The mean control rate was 3.94uM glucose/gram
tissue/hour, whereas the ob/ob rate dropped slightly to
1.57uM (Table 2; Figure 2). At each concentration the mean
rate of glucose utilization by obese and control mice
tissues differed at a highly significant level (Table 2).
This was demonstrated by the Student t-test in which the
level of significance was at 0.01.
Results of the ob/ob pancreatic tissue incubations were
highly erratic. The ob/ob pancreatic islet utilization mean
was 69pM glucose/islet/hour at 100 mg/d1. The standard
deviation was 19. The control tissue utilization rate was
55.5pM glucose/islet/hour. The standard deviation was 4.9
The ob/ob islets exhibited a utilization rate of 85.1pM
glucose/islet/hour at 200 medl glucose concentration. The
standard deviation was 29. The control rate of glucose
utilization at 200 mg/di wPr, 138pM/i3let/hour. The standard
deviation was 15. Because of the erratic nature of the ob/ob
islet incubation results, they were not included in the
graphic presentation.
DISCUSSION
The defective glucose utilization demonstrated in
erythrocytes was further evidence that the primary defect
in the obese mouse was not a localized one. The presence
of defective glycolysis in erythrocytes also indicated
that the problem was not strictly insulin related. Hyper-
insulinism or insulin resistance may have been implicated
previously as the primary defect in the syndrome because
of the effect of that hormone on the large tissue masses
of the animal   muscle and adipose.
The significance of a decreased rate of glucose
utilization in adipose tissue of the obese mouse was
emphasized by the conditions of the incubations. Washed
objob epididymal fat segments, in the absence of insulin
or any exogenous hormone, demonstrated a slower rate of
glucose metabolism. This observation reinforced the idea
that the condition was not caused by external factors, but
more likely as a result of a defect in the adipose tissue.
The difference in rates of utilization persisted in the
various glucose concentrations, ranging from that which
would correspond to an abnormally low blood sugar level to
a normal, high value (Lavin et al. 19771 7,arthwaite et al.
1980). That the adipose tissue defect was not entirely
16
17
the result of an insulin effect was supported by Abraham and
Beloff-Chain (1971). They showed that a restricted diet
improved the hypergly^.emia and insulin resistant conditions,
but did not reduce the hyperinsulinism or obesity, indicating
that the insulin resistance was not the original problem in
the adipose tissue.
The erratic results obtained by incubation of islets
from ob(ob mice could not be used for any useful calculations,
but some information may be provided by these findings. The
islets of the obese mice were observed to be larger than the
control islets. Other authors have also reported ob/Ob
islets to be larger and more fragile than normal islets
(Findlay et al. 1973; Lavine et al. 1977). The erratic
results obtained might nave resulted from the larger and
more fragile ob/Ob islets disrupting during incubation.
While the results of the incubation of the fat segments
suggested an intracellular defect, the evidence gleaned from
the erythrocyte studies was more indicative of a primary
problem. It has been shown that glucose transport and
metabolism in erythrocytes are not regulated by insulin and
that that glucose metabolism is not dependent upon the rate
of glucose transport Elbrink and Bihler, 1975). Also, in
erythrocytes glucose is metabolized only by glycolysis and
the pentose phosphate pathway, the former accounting for
about ninety percent of the cells' metabolism. The cells
used were washed several times and laced in a hormone-free
medium. rhecceatenne of defective glucose metabolism in
18
erythrocytes under these conditions provided supporting
evidence that hyperinsulinism, insulin resistance, or hyper-
glycemia were not the primary cause of the syndrome. The
report of Cuendet et al. (1976), which stated that In ijara
skeletal muscle exhibited defective glucose uptake and
metabolism, supported the idea of a generalized cellular
defect. The authors also suggested that the same defect
may occur in the ventromedial hypothalamus, resulting in a
tendency to hyperphagia, which would lead to hyperglycemia,
ultimately causing hyperinsulinism. The hyperinsulinism
would result in insulin resistance and compound a problem
already existing in the muscle tissue. Bereiter and
Jeanrenaud (1979) and Van der Kroan and Speijers (1979)
reported anatomical deficiencies in the VMH of the cb/Ob
mouse which reinforces this theory. This idea was also
supported by Baile et al. (1970). The possibility of a
hypothalmic lesion being the primary defect has been given
little support. According to Stauffacher and Renold (1969)
and Kasuga et al. (1980), a VMH lesion was not solely
responsible for the syndrome. They showed that mice with a
VMH lesion did not exhibit the severity of symptoms seen in
the ob/ob mouse, indicating that there was another factor at
work in the development of the syndrome. The results again
supported the idea of a localized defect. ?urther investi-
gations of the glucose utilization in individual tissues,
especially those not sensitive to insulin, are needed to
help determine the significance of the evidence supporting
19
this possibility.
The ob/ob mouse is consijered an important experimental
model for non-insulin dependent diabetes (Carnie and Smith
19801 Carthwaite et al. 1980). The importance, therefore,
of increased understanding of this mutation is not only
valuable for the study of inborn errors of metabolism in the
experimental animal, but in the possible application of tnat
knowledge to a better understanding of some forms of non-
insulin dependent diabetes in humans as well.
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